The use of specific-allergen immunotherapy in the treatment of allergic rhinitis was associated with significant cost savings for the Florida Medicaid program. Overall savings during the first 18 months of allergen immunotherapy treatment were $5,921 in the pediatric Medicaid population and $7,286 for adults. On a percentage basis, specific-allergen immunotherapy produced a remarkable 41% and 52% savings in adults and children, respectively. Prior controlled clinical studies have demonstrated that specific-allergen immunotherapy prevents the progression of IgE-mediated diseases, and here we reveal that allergen immunotherapy also reduces dramatically the overall costs of caring for allergic rhinitis patient populations. In patient populations with allergic rhinitis, therefore, specific-allergen immunotherapy is associated with both better outcomes and significantly reduced overall costs.
Asthma is an inflammatory disease of the bronchial airways associated with airway hyperreactivity. Symptoms include coughing, wheezing, dyspnea, chest tightness and congestion that affects more than 10% of Americans.
What is Asthma?Allergists are investigators in identifying offending allergens that are important in destabilizing asthma. All patients and especially children with asthma need to have continued access to asthma specialty care.
Asthma TreamentsLocate a Board Certified Allergist close to you! Massachusetts Allergy and Asthma Society members are certified and trained to find the source of your symptoms, treat it and help you feel healthy again.
Find an Allergist